首页 > 最新文献

Annals of Medicine and Surgery最新文献

英文 中文
Diagnostic role of Ki-67 expression in distinguishing thyroid follicular carcinoma from follicular adenoma: a systematic review and meta-analysis. Ki-67表达在区分甲状腺滤泡癌和滤泡腺瘤中的诊断作用:一项系统回顾和荟萃分析。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-12-18 eCollection Date: 2026-02-01 DOI: 10.1097/MS9.0000000000004503
Rayehe Rahimi, Fakhrieh Kalavari, Yalda Ashoorian, Mohammad Amin Ashoobi, Enayatollah Homaie Rad, Saeid Anvari

Background: Differentiating follicular thyroid carcinoma (FTC) from follicular adenoma (FA) is challenging due to their histological similarities. This systematic review and meta-analysis aimed to assess the difference in Ki-67 expression between FTC and FA to evaluate its diagnostic utility.

Methods: We conducted a comprehensive search of PubMed, Embase, Scopus, and Web of Science databases for studies reporting Ki-67 expression in FTC and FA. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. A random-effects model was applied to calculate the pooled mean difference of the Ki-67 index, with heterogeneity assessed by the Cochran Q and I-squared tests. Meta-regression was used to explore sources of heterogeneity, and publication bias was evaluated using Egger's test, Begg's test, and funnel plot.

Results: The meta-analysis revealed a pooled mean difference in Ki-67 expression between FTC and FA of 1.13 (0.63-1.63), indicating a significant difference. In addition, the difference in the Ki-67 index between minimally invasive follicular carcinoma and FA was 0.56 (0.12-1.00), which was also statistically significant. The heterogeneity among included studies was due to variations in Ki-67 index calculation methods. The reviewed studies demonstrated low sensitivity but high specificity of Ki-67 for differentiating FTC vs. FA, although diagnostic cut-offs were inconsistent.

Conclusions: This study demonstrates a significant difference in Ki-67 expression between FTC and FA, supporting its potential role as a diagnostic marker. Further research is required to establish standardized diagnostic cut-offs and evaluate Ki-67's sensitivity and specificity in clinical practice.

背景:区分滤泡性甲状腺癌(FTC)和滤泡性腺瘤(FA)是具有挑战性的,因为它们的组织学相似。本系统综述和荟萃分析旨在评估Ki-67表达在FTC和FA之间的差异,以评估其诊断价值。方法:我们对PubMed, Embase, Scopus和Web of Science数据库进行了全面的检索,以报告FTC和FA中Ki-67表达的研究。纳入研究的质量采用纽卡斯尔-渥太华量表进行评估。采用随机效应模型计算Ki-67指数的汇总均差,采用Cochran Q检验和i²检验评估异质性。meta回归分析异质性来源,发表偏倚评价采用Egger检验、Begg检验和漏斗图。结果:荟萃分析显示,FTC与FA之间Ki-67表达的汇总平均差异为1.13(0.63-1.63),差异具有统计学意义。此外,微创滤泡癌与FA的Ki-67指数差异为0.56(0.12-1.00),差异亦有统计学意义。纳入研究的异质性是由于Ki-67指数计算方法的差异。所回顾的研究表明,Ki-67在鉴别FTC和FA方面敏感性低,但特异性高,尽管诊断截止值不一致。结论:本研究表明Ki-67在FTC和FA之间的表达有显著差异,支持其作为诊断标志物的潜在作用。在临床实践中,需要进一步的研究来建立标准化的诊断临界值,并评估Ki-67的敏感性和特异性。
{"title":"Diagnostic role of Ki-67 expression in distinguishing thyroid follicular carcinoma from follicular adenoma: a systematic review and meta-analysis.","authors":"Rayehe Rahimi, Fakhrieh Kalavari, Yalda Ashoorian, Mohammad Amin Ashoobi, Enayatollah Homaie Rad, Saeid Anvari","doi":"10.1097/MS9.0000000000004503","DOIUrl":"10.1097/MS9.0000000000004503","url":null,"abstract":"<p><strong>Background: </strong>Differentiating follicular thyroid carcinoma (FTC) from follicular adenoma (FA) is challenging due to their histological similarities. This systematic review and meta-analysis aimed to assess the difference in Ki-67 expression between FTC and FA to evaluate its diagnostic utility.</p><p><strong>Methods: </strong>We conducted a comprehensive search of PubMed, Embase, Scopus, and Web of Science databases for studies reporting Ki-67 expression in FTC and FA. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. A random-effects model was applied to calculate the pooled mean difference of the Ki-67 index, with heterogeneity assessed by the Cochran <i>Q</i> and <i>I</i>-squared tests. Meta-regression was used to explore sources of heterogeneity, and publication bias was evaluated using Egger's test, Begg's test, and funnel plot.</p><p><strong>Results: </strong>The meta-analysis revealed a pooled mean difference in Ki-67 expression between FTC and FA of 1.13 (0.63-1.63), indicating a significant difference. In addition, the difference in the Ki-67 index between minimally invasive follicular carcinoma and FA was 0.56 (0.12-1.00), which was also statistically significant. The heterogeneity among included studies was due to variations in Ki-67 index calculation methods. The reviewed studies demonstrated low sensitivity but high specificity of Ki-67 for differentiating FTC vs. FA, although diagnostic cut-offs were inconsistent.</p><p><strong>Conclusions: </strong>This study demonstrates a significant difference in Ki-67 expression between FTC and FA, supporting its potential role as a diagnostic marker. Further research is required to establish standardized diagnostic cut-offs and evaluate Ki-67's sensitivity and specificity in clinical practice.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 2","pages":"1695-1705"},"PeriodicalIF":1.6,"publicationDate":"2026-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term safety and effectiveness of hybrid coronary revascularization compared to conventional revascularization strategies: a systematic review and meta-analysis. 与传统冠脉重建术相比,混合冠脉重建术的长期安全性和有效性:一项系统回顾和荟萃分析。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-12-11 eCollection Date: 2026-02-01 DOI: 10.1097/MS9.0000000000004561
Singam Shashank, Rashmikaa Netyam, Chiranjeevee R Saravanan, Nikhil D Kolanu, Nanditha Karra, Harshada S Keluskar, Ziad Helaly, Mohammed H Albitar, Abdullah Sharbek, Seba Albitar, Pugazhendi Inban, Mohammed D M Marsool, Omniat A Hussin

Background: Hybrid coronary revascularization (HCR), a combination of percutaneous coronary intervention and coronary artery bypass grafting (CABG), is an emerging treatment for patients with multivessel coronary artery disease (MVCAD). While traditional CABG is considered the standard, HCR may mitigate issues like saphenous vein graft failure.

Methods: We systematically searched PubMed, Scopus, Web of Science, and Embase until September 2024, targeting randomized controlled trials (RCTs) that evaluated HCR against CABG in MVCAD patients. The quality of included studies was assessed using the ROB2 tool, and data were analyzed using RevMan 5.4. Four RCTs (n = 382) involving 382 participants were analyzed using a random-effects model. Risk of bias was assessed using the ROB2 tool.

Results: Four RCTs (n = 382) met inclusion criteria. At 30 days, there were no statistically significant differences between HCR and CABG in all-cause death (risk ratios [RR] = 1.35, P = 0.74), stroke (RR = 0.99, P = 0.99), myocardial infarction (RR = 1.17, P = 0.74), or blood transfusion (RR = 0.70, P = 0.14), with zero heterogeneity (I 2 = 0%). At 1-year follow-up, pooled analyses showed no significant differences in all-cause death (RR = 1.37, P = 0.62) or myocardial infarction (RR = 1.29, P = 0.56), also with consistent homogeneity (I 2 = 0%).

Conclusion: HCR demonstrates comparable safety and effectiveness to CABG for MVCAD, with similar rates of key outcomes at both 30 days and 1 year. Further research with larger samples and longer follow-up is recommended to confirm these findings.

背景:混合冠状动脉血管重建术(HCR)是一种经皮冠状动脉介入治疗和冠状动脉旁路移植术(CABG)相结合的治疗方法,是治疗多支冠状动脉疾病(MVCAD)的新方法。虽然传统的冠脉搭桥被认为是标准的,但HCR可以减轻隐静脉移植失败等问题。方法:我们系统地检索PubMed, Scopus, Web of Science和Embase,直到2024年9月,目标是随机对照试验(rct),评估HCR对MVCAD患者CABG的影响。采用ROB2工具评估纳入研究的质量,并使用RevMan 5.4对数据进行分析。采用随机效应模型对4项随机对照试验(n = 382) 382名受试者进行分析。使用ROB2工具评估偏倚风险。结果:4项rct (n = 382)符合纳入标准。30天时,HCR和CABG在全因死亡(风险比[RR] = 1.35, P = 0.74)、卒中(风险比[RR = 0.99, P = 0.99)、心肌梗死(风险比[RR = 1.17, P = 0.74)、输血(风险比[RR = 0.70, P = 0.14)方面无统计学差异,异质性为零(2 = 0%)。在1年的随访中,合并分析显示全因死亡(RR = 1.37, P = 0.62)或心肌梗死(RR = 1.29, P = 0.56)无显著差异,也具有一致的均匀性(I 2 = 0%)。结论:HCR对MVCAD的安全性和有效性与CABG相当,30天和1年的关键结局率相似。建议进行更大样本和更长时间随访的进一步研究,以证实这些发现。
{"title":"Long-term safety and effectiveness of hybrid coronary revascularization compared to conventional revascularization strategies: a systematic review and meta-analysis.","authors":"Singam Shashank, Rashmikaa Netyam, Chiranjeevee R Saravanan, Nikhil D Kolanu, Nanditha Karra, Harshada S Keluskar, Ziad Helaly, Mohammed H Albitar, Abdullah Sharbek, Seba Albitar, Pugazhendi Inban, Mohammed D M Marsool, Omniat A Hussin","doi":"10.1097/MS9.0000000000004561","DOIUrl":"10.1097/MS9.0000000000004561","url":null,"abstract":"<p><strong>Background: </strong>Hybrid coronary revascularization (HCR), a combination of percutaneous coronary intervention and coronary artery bypass grafting (CABG), is an emerging treatment for patients with multivessel coronary artery disease (MVCAD). While traditional CABG is considered the standard, HCR may mitigate issues like saphenous vein graft failure.</p><p><strong>Methods: </strong>We systematically searched PubMed, Scopus, Web of Science, and Embase until September 2024, targeting randomized controlled trials (RCTs) that evaluated HCR against CABG in MVCAD patients. The quality of included studies was assessed using the ROB2 tool, and data were analyzed using RevMan 5.4. Four RCTs (<i>n</i> = 382) involving 382 participants were analyzed using a random-effects model. Risk of bias was assessed using the ROB2 tool.</p><p><strong>Results: </strong>Four RCTs (<i>n</i> = 382) met inclusion criteria. At 30 days, there were no statistically significant differences between HCR and CABG in all-cause death (risk ratios [RR] = 1.35, <i>P</i> = 0.74), stroke (RR = 0.99, <i>P</i> = 0.99), myocardial infarction (RR = 1.17, <i>P</i> = 0.74), or blood transfusion (RR = 0.70, <i>P</i> = 0.14), with zero heterogeneity (<i>I</i> <sup>2</sup> = 0%). At 1-year follow-up, pooled analyses showed no significant differences in all-cause death (RR = 1.37, <i>P</i> = 0.62) or myocardial infarction (RR = 1.29, <i>P</i> = 0.56), also with consistent homogeneity (<i>I</i> <sup>2</sup> = 0%).</p><p><strong>Conclusion: </strong>HCR demonstrates comparable safety and effectiveness to CABG for MVCAD, with similar rates of key outcomes at both 30 days and 1 year. Further research with larger samples and longer follow-up is recommended to confirm these findings.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 2","pages":"1779-1788"},"PeriodicalIF":1.6,"publicationDate":"2026-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of probiotics on psychological issues in people with fibromyalgia: a systematic review. 益生菌对纤维肌痛患者心理问题的影响:一项系统综述。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-25 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004726
Amin Nakhostin-Ansari, Negin Khosravipour, Sara Pedram Jafari, Shahdad Ahmadi, Zahra Rabiei, Negar Khorasani, Atousa Janzadeh

Background: In this systematic review, we aimed to evaluate the impacts of probiotics on psychological issues and other symptoms, such as pain and fatigue, in people with fibromyalgia.

Materials and methods: On 19 January 2025, PubMed, Scopus, and Web of Science were searched to identify relevant records. We included studies that evaluated the effects of probiotics, either alone or in combination with other treatments, in individuals diagnosed with fibromyalgia, compared to the placebo or any other form of treatment. The quality of the included studies was assessed using the JBI critical appraisal tools for randomized controlled trials and quasi-experimental studies. We used a qualitative approach for the synthesis in this study.

Results: From a total of 186 articles retrieved in our search, five reports from four studies were included in this review. In total, 209 people with fibromyalgia were included in these studies, with 103 (49.3%) being in the experimental (probiotic) group. All studies fulfilled the majority of the JBI critical appraisal tool criteria. Although some studies reported reductions in anxiety and depression among individuals with fibromyalgia who used probiotics, the findings were not consistent across all studies. Only one study assessed adverse events associated with probiotics compared to placebo, finding no significant differences between the groups in the incidence of at least one adverse event (P > 0.05).

Conclusions: Overall, we cannot make a definitive recommendation for or against the use of probiotics in the treatment of individuals with fibromyalgia, and future studies are needed in this regard.

背景:在这篇系统综述中,我们旨在评估益生菌对纤维肌痛患者的心理问题和其他症状(如疼痛和疲劳)的影响。材料和方法:于2025年1月19日检索PubMed、Scopus和Web of Science以确定相关记录。我们纳入了评估益生菌对纤维肌痛患者的影响的研究,无论是单独使用还是与其他治疗方法联合使用,与安慰剂或任何其他形式的治疗方法相比。采用JBI随机对照试验和准实验研究的关键评价工具对纳入研究的质量进行评估。在本研究中,我们采用了定性方法进行合成。结果:从我们检索到的186篇文章中,来自4项研究的5篇报告被纳入本综述。总共有209名纤维肌痛患者被纳入这些研究,其中103人(49.3%)被纳入实验(益生菌)组。所有的研究都满足了JBI关键评估工具的大部分标准。尽管一些研究报告说,纤维肌痛患者使用益生菌后焦虑和抑郁有所减少,但并不是所有研究的结果都一致。只有一项研究评估了与安慰剂相比益生菌相关的不良事件,发现两组之间至少有一项不良事件的发生率没有显著差异(P < 0.05)。结论:总的来说,我们不能明确推荐或反对使用益生菌治疗纤维肌痛,需要在这方面进行进一步的研究。
{"title":"Effects of probiotics on psychological issues in people with fibromyalgia: a systematic review.","authors":"Amin Nakhostin-Ansari, Negin Khosravipour, Sara Pedram Jafari, Shahdad Ahmadi, Zahra Rabiei, Negar Khorasani, Atousa Janzadeh","doi":"10.1097/MS9.0000000000004726","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004726","url":null,"abstract":"<p><strong>Background: </strong>In this systematic review, we aimed to evaluate the impacts of probiotics on psychological issues and other symptoms, such as pain and fatigue, in people with fibromyalgia.</p><p><strong>Materials and methods: </strong>On 19 January 2025, PubMed, Scopus, and Web of Science were searched to identify relevant records. We included studies that evaluated the effects of probiotics, either alone or in combination with other treatments, in individuals diagnosed with fibromyalgia, compared to the placebo or any other form of treatment. The quality of the included studies was assessed using the JBI critical appraisal tools for randomized controlled trials and quasi-experimental studies. We used a qualitative approach for the synthesis in this study.</p><p><strong>Results: </strong>From a total of 186 articles retrieved in our search, five reports from four studies were included in this review. In total, 209 people with fibromyalgia were included in these studies, with 103 (49.3%) being in the experimental (probiotic) group. All studies fulfilled the majority of the JBI critical appraisal tool criteria. Although some studies reported reductions in anxiety and depression among individuals with fibromyalgia who used probiotics, the findings were not consistent across all studies. Only one study assessed adverse events associated with probiotics compared to placebo, finding no significant differences between the groups in the incidence of at least one adverse event (<i>P</i> > 0.05).</p><p><strong>Conclusions: </strong>Overall, we cannot make a definitive recommendation for or against the use of probiotics in the treatment of individuals with fibromyalgia, and future studies are needed in this regard.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2383-2392"},"PeriodicalIF":1.6,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periodontitis and respiratory infections - exploring the oral-systemic link. 牙周炎和呼吸道感染——探索口腔与全身的联系。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-24 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004374
Shreya Singh Beniwal, Yash Satish Caroicar, Kashyapi Patil, Akash Rawat, Adam Sheikh Said, Hari Vorappan Manickavelan, Arusha Desai, Het Tushar Jani, Rafael Everton Assunção Ribeiro da Costa, Alyanna Cabe Cacas, Chandramani Panjabi, Ayush Dwivedi

Periodontitis is a chronic inflammatory disorder that has been recognized as a significant public health concern worldwide. An imbalance between the protective oral microbiota and numerous oral pathogens has been implicated in its pathogenesis. Periodontitis not only impacts an individual's oral health but also has systemic implications. The pathogenesis of periodontitis and these respiratory infections has been shown to be intricately linked. Numerous clinical research and animal studies have highlighted that the oral health of a population is closely related to their systemic health. It has been suggested that the periodontal pockets can act as a reservoir for oral pathogens, which can later migrate into the respiratory tract through aspiration or systemic circulation. This is a narrative review conducted after a wide literature search on databases such as PubMed, Cochrane, and Google Scholar with keywords including "Periodontitis," "Respiratory," "Infections," "Tuberculosis," 'COVID-19', "Pneumonia," "Asthma," and "COPD" published in the last 15 years. The cornerstone of this comprehensive review lies in deciphering the pathogenesis and epidemiology of periodontitis and how these periodontal bacteria contribute to respiratory infections through numerous biological mechanisms, inflammatory pathways, and the potential pathways of infection transmission. We also explore the empirical evidence through research studies supporting the periodontitis-respiratory infections link and also studies with conflicting or inconclusive results. By connecting the dots between this crucial oral-systemic link, we hope to uncover the gaps in the current research and find new avenues for developing cost-effective, targeted, transformative preventive and therapeutic strategies that will not only improve oral health but will also support respiratory health and help reduce the global burden of respiratory infections. Strengthening oral hygiene programs could reduce the burden of respiratory diseases, particularly in elderly and high-risk populations.

牙周炎是一种慢性炎症性疾病,已被公认为世界范围内的重大公共卫生问题。保护性口腔微生物群与众多口腔病原体之间的不平衡与其发病机制有关。牙周炎不仅影响个人的口腔健康,而且具有全身性的影响。牙周炎的发病机制和这些呼吸道感染已被证明是错综复杂的联系。大量的临床研究和动物实验都强调了一个人群的口腔健康与其全身健康密切相关。有人认为,牙周袋可以作为口腔病原体的储存库,这些病原体随后可以通过吸入或体循环迁移到呼吸道。这是在PubMed、Cochrane和谷歌Scholar等数据库中进行广泛文献检索后进行的叙叙性综述,关键词包括“牙周炎”、“呼吸道”、“感染”、“结核病”、“COVID-19”、“肺炎”、“哮喘”和“COPD”,发表于过去15年。这项综合综述的基础在于破解牙周炎的发病机制和流行病学,以及这些牙周细菌如何通过多种生物学机制、炎症途径和感染传播的潜在途径导致呼吸道感染。我们还通过研究支持牙周炎与呼吸道感染之间的联系,以及有冲突或不确定结果的研究来探索经验证据。通过将这一至关重要的口腔-系统联系联系起来,我们希望发现当前研究中的空白,并找到开发具有成本效益,有针对性,变革性的预防和治疗策略的新途径,这些策略不仅可以改善口腔健康,还可以支持呼吸健康并帮助减轻全球呼吸道感染负担。加强口腔卫生计划可以减轻呼吸道疾病的负担,特别是在老年人和高危人群中。
{"title":"Periodontitis and respiratory infections - exploring the oral-systemic link.","authors":"Shreya Singh Beniwal, Yash Satish Caroicar, Kashyapi Patil, Akash Rawat, Adam Sheikh Said, Hari Vorappan Manickavelan, Arusha Desai, Het Tushar Jani, Rafael Everton Assunção Ribeiro da Costa, Alyanna Cabe Cacas, Chandramani Panjabi, Ayush Dwivedi","doi":"10.1097/MS9.0000000000004374","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004374","url":null,"abstract":"<p><p>Periodontitis is a chronic inflammatory disorder that has been recognized as a significant public health concern worldwide. An imbalance between the protective oral microbiota and numerous oral pathogens has been implicated in its pathogenesis. Periodontitis not only impacts an individual's oral health but also has systemic implications. The pathogenesis of periodontitis and these respiratory infections has been shown to be intricately linked. Numerous clinical research and animal studies have highlighted that the oral health of a population is closely related to their systemic health. It has been suggested that the periodontal pockets can act as a reservoir for oral pathogens, which can later migrate into the respiratory tract through aspiration or systemic circulation. This is a narrative review conducted after a wide literature search on databases such as PubMed, Cochrane, and Google Scholar with keywords including \"Periodontitis,\" \"Respiratory,\" \"Infections,\" \"Tuberculosis,\" 'COVID-19', \"Pneumonia,\" \"Asthma,\" and \"COPD\" published in the last 15 years. The cornerstone of this comprehensive review lies in deciphering the pathogenesis and epidemiology of periodontitis and how these periodontal bacteria contribute to respiratory infections through numerous biological mechanisms, inflammatory pathways, and the potential pathways of infection transmission. We also explore the empirical evidence through research studies supporting the periodontitis-respiratory infections link and also studies with conflicting or inconclusive results. By connecting the dots between this crucial oral-systemic link, we hope to uncover the gaps in the current research and find new avenues for developing cost-effective, targeted, transformative preventive and therapeutic strategies that will not only improve oral health but will also support respiratory health and help reduce the global burden of respiratory infections. Strengthening oral hygiene programs could reduce the burden of respiratory diseases, particularly in elderly and high-risk populations.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2312-2324"},"PeriodicalIF":1.6,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency and correlates of somatic symptoms in patients of depression: a cross-sectional study at PIMS Islamabad. 抑郁症患者躯体症状的频率和相关因素:伊斯兰堡PIMS的横断面研究
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-23 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004804
Fatima Rizwan Bhatti, Remsha Tariq, Rida Hussain, Muddassir Khalid, Sumia Fatima, Laiba Fatima, Qamar Shoukat

Background: Essentially crucial in early diagnosis and treatment of depression are the somatic symptoms, which can significantly decrease the morbidity and mortality associated with these symptoms and depression, as well as decrease the costs of investigation and treatment for the primary healthcare system. We conducted this study to determine the socio-demographic correlates of somatic symptoms in depression in a Pakistani population.

Methods: This cross-sectional study was conducted at the Department of Psychiatry, PIMS Hospital, Islamabad, during the period April 2025 to August 2025. A total of 243 male and female patients aged 12-60 years diagnosed with depression were enrolled. The patients were evaluated for somatic symptoms by conducting an interview based on the PHQ-15 questionnaire. Data was analyzed using SPSS v.26. The primary objective was to determine the prevalence of somatic symptom severity using PHQ-15 categories among patients with DSM-5-diagnosed depression. Secondary objectives were to examine associations between PHQ-15 severity and key sociodemographic predictors including age, gender, education, residence, and marital status.

Results: Gender wise distribution of the patients revealed that 74 males (30.5%) and 169 females (69.5%). In terms of age distribution, the largest age group was 12-25 years (n = 131, 53.9%), followed by 26-35 years (n = 63, 25.9%). Among the symptoms that bothered the patients a lot, low energy was most frequently reported by 144 patients (59.3%), followed by troubled sleeping by 117 (48.1%). Painful sexual intercourse was least commonly reported by 9 patients (3.7%). High PHQ-15 score was recorded in 52 patients (39.7%), aged 12-25 years, 26 (41.3%) patients aged 26-35 years, 12 (48.0%) patients aged 36-45 years, and 17 (70.8%) patients aged 46-60 years, respectively (P-value 0.011).

Conclusion: Most frequently reported somatic symptoms significantly bothering the patients were low energy and trouble sleeping. Age was significantly associated with the degree of somatization, and patients with advanced age were more frequently having a high degree of somatization.

背景:躯体症状对抑郁症的早期诊断和治疗至关重要,它可以显著降低与这些症状和抑郁症相关的发病率和死亡率,并减少初级卫生保健系统的调查和治疗费用。我们进行了这项研究,以确定巴基斯坦人群中抑郁症躯体症状的社会人口学相关性。方法:本横断面研究于2025年4月至2025年8月在伊斯兰堡PIMS医院精神科进行。共招募了243名年龄在12-60岁之间被诊断为抑郁症的男性和女性患者。通过基于PHQ-15问卷的访谈来评估患者的躯体症状。数据分析采用SPSS v.26。主要目的是使用PHQ-15分类确定dsm -5诊断的抑郁症患者中躯体症状严重程度的患病率。次要目的是检查PHQ-15严重程度与主要社会人口学预测因子(包括年龄、性别、教育程度、居住地和婚姻状况)之间的关系。结果:患者性别分布男性74例(30.5%),女性169例(69.5%)。从年龄分布来看,以12-25岁年龄组最多(n = 131, 53.9%),其次为26-35岁年龄组(n = 63, 25.9%)。在困扰患者较多的症状中,以精力不足最为常见的144例(59.3%),其次是睡眠困难117例(48.1%)。最不常见的是性交疼痛,9例(3.7%)。PHQ-15评分较高的患者有52例(39.7%),年龄为12-25岁,26-35岁26例(41.3%),36-45岁12例(48.0%),46-60岁17例(70.8%)(p值为0.011)。结论:最常报告的躯体症状是低能和睡眠困难。年龄与躯体化程度显著相关,高龄患者躯体化程度较高。
{"title":"Frequency and correlates of somatic symptoms in patients of depression: a cross-sectional study at PIMS Islamabad.","authors":"Fatima Rizwan Bhatti, Remsha Tariq, Rida Hussain, Muddassir Khalid, Sumia Fatima, Laiba Fatima, Qamar Shoukat","doi":"10.1097/MS9.0000000000004804","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004804","url":null,"abstract":"<p><strong>Background: </strong>Essentially crucial in early diagnosis and treatment of depression are the somatic symptoms, which can significantly decrease the morbidity and mortality associated with these symptoms and depression, as well as decrease the costs of investigation and treatment for the primary healthcare system. We conducted this study to determine the socio-demographic correlates of somatic symptoms in depression in a Pakistani population.</p><p><strong>Methods: </strong>This cross-sectional study was conducted at the Department of Psychiatry, PIMS Hospital, Islamabad, during the period April 2025 to August 2025. A total of 243 male and female patients aged 12-60 years diagnosed with depression were enrolled. The patients were evaluated for somatic symptoms by conducting an interview based on the PHQ-15 questionnaire. Data was analyzed using SPSS v.26. The primary objective was to determine the prevalence of somatic symptom severity using PHQ-15 categories among patients with DSM-5-diagnosed depression. Secondary objectives were to examine associations between PHQ-15 severity and key sociodemographic predictors including age, gender, education, residence, and marital status.</p><p><strong>Results: </strong>Gender wise distribution of the patients revealed that 74 males (30.5%) and 169 females (69.5%). In terms of age distribution, the largest age group was 12-25 years (<i>n</i> = 131, 53.9%), followed by 26-35 years (<i>n</i> = 63, 25.9%). Among the symptoms that bothered the patients a lot, low energy was most frequently reported by 144 patients (59.3%), followed by troubled sleeping by 117 (48.1%). Painful sexual intercourse was least commonly reported by 9 patients (3.7%). High PHQ-15 score was recorded in 52 patients (39.7%), aged 12-25 years, 26 (41.3%) patients aged 26-35 years, 12 (48.0%) patients aged 36-45 years, and 17 (70.8%) patients aged 46-60 years, respectively (<i>P</i>-value 0.011).</p><p><strong>Conclusion: </strong>Most frequently reported somatic symptoms significantly bothering the patients were low energy and trouble sleeping. Age was significantly associated with the degree of somatization, and patients with advanced age were more frequently having a high degree of somatization.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2262-2268"},"PeriodicalIF":1.6,"publicationDate":"2026-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sinus bradycardia as an atypical presentation of severe hypercalcemia: a case report and a literature review. 窦性心动过缓作为严重高钙血症的非典型表现:1例报告和文献复习。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-20 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004802
Besher Shami, Riyadh Saif, Iman Mousselli, Souhila Belhandouz, Hafsa Ashraf, Katherin Zambrano, Mostafa Helou, Kalpana Chilukuri, Pradeep Manoharan

Introduction and importance: Severe hypercalcemia typically produces QT interval shortening or ventricular arrhythmias, whereas bradyarrhythmias are exceptionally rare. The coexistence of hypercalcemia with acute kidney injury (AKI) - a condition that usually causes hypocalcemia - further underscores diagnostic complexity.

Case presentation: An 85-year-old man presented with AKI, confusion, and symptomatic sinus bradycardia (40 bpm) without atrioventricular block or QT prolongation. Laboratory studies showed markedly elevated corrected calcium, suppressed parathyroid hormone, and increased parathyroid hormone-related peptide. Chest CT revealed a 7 × 8 mm right-lung nodule. These findings are suggestive of humoral hypercalcemia of malignancy, although the etiology remains unconfirmed in the absence of tissue diagnosis. Treatment with intravenous hydration and zoledronic acid led to normalization of calcium, restoration of sinus rhythm (61 bpm), and improvement of renal function, obviating the need for pacing.

Discussion: This case is distinctive for demonstrating reversible sinus bradycardia in the setting of severe hypercalcemia and acute kidney injury - an atypical and physiologically unexpected combination. The biochemical profile raises suspicion for a paraneoplastic process, though this remains unconfirmed. The case underscores the importance of recognizing hypercalcemia as a reversible cause of bradyarrhythmia and considering malignancy in the appropriate clinical context when PTH is suppressed.

Conclusion: Hypercalcemia-induced bradycardia, though rare, is fully reversible with prompt metabolic correction. Awareness of this atypical presentation can prevent misdiagnosis, unnecessary pacemaker implantation, and delayed recognition of paraneoplastic disease.

简介和重要性:严重的高钙血症通常会导致QT间期缩短或室性心律失常,而慢性心律失常则极为罕见。高钙血症与急性肾损伤(AKI)共存,这种情况通常会导致低钙血症,这进一步强调了诊断的复杂性。病例介绍:一名85岁男性,表现为AKI、精神错乱和症状性窦性心动过缓(40 bpm),无房室传导阻滞或QT间期延长。实验室研究显示校正钙明显升高,甲状旁腺激素抑制,甲状旁腺激素相关肽增加。胸部CT示右肺7 × 8 mm结节。这些发现提示恶性肿瘤的体液性高钙血症,尽管病因在缺乏组织诊断的情况下仍未得到证实。静脉水化和唑来膦酸治疗导致钙恢复正常,窦性心律(61 bpm)恢复,肾功能改善,无需起搏。讨论:该病例的特点是在严重高钙血症和急性肾损伤的情况下表现出可逆性窦性心动过缓,这是一种非典型和生理上意想不到的组合。生化特征引起了对副肿瘤过程的怀疑,尽管这仍未得到证实。该病例强调了认识到高钙血症是缓性心律失常的可逆原因的重要性,当PTH被抑制时,在适当的临床背景下考虑恶性肿瘤。结论:高钙血症引起的心动过缓虽然罕见,但通过及时的代谢纠正是完全可逆的。意识到这种不典型的表现可以防止误诊、不必要的起搏器植入和对副肿瘤疾病的延迟识别。
{"title":"Sinus bradycardia as an atypical presentation of severe hypercalcemia: a case report and a literature review.","authors":"Besher Shami, Riyadh Saif, Iman Mousselli, Souhila Belhandouz, Hafsa Ashraf, Katherin Zambrano, Mostafa Helou, Kalpana Chilukuri, Pradeep Manoharan","doi":"10.1097/MS9.0000000000004802","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004802","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Severe hypercalcemia typically produces QT interval shortening or ventricular arrhythmias, whereas bradyarrhythmias are exceptionally rare. The coexistence of hypercalcemia with acute kidney injury (AKI) - a condition that usually causes hypocalcemia - further underscores diagnostic complexity.</p><p><strong>Case presentation: </strong>An 85-year-old man presented with AKI, confusion, and symptomatic sinus bradycardia (40 bpm) without atrioventricular block or QT prolongation. Laboratory studies showed markedly elevated corrected calcium, suppressed parathyroid hormone, and increased parathyroid hormone-related peptide. Chest CT revealed a 7 × 8 mm right-lung nodule. These findings are suggestive of humoral hypercalcemia of malignancy, although the etiology remains unconfirmed in the absence of tissue diagnosis. Treatment with intravenous hydration and zoledronic acid led to normalization of calcium, restoration of sinus rhythm (61 bpm), and improvement of renal function, obviating the need for pacing.</p><p><strong>Discussion: </strong>This case is distinctive for demonstrating reversible sinus bradycardia in the setting of severe hypercalcemia and acute kidney injury - an atypical and physiologically unexpected combination. The biochemical profile raises suspicion for a paraneoplastic process, though this remains unconfirmed. The case underscores the importance of recognizing hypercalcemia as a reversible cause of bradyarrhythmia and considering malignancy in the appropriate clinical context when PTH is suppressed.</p><p><strong>Conclusion: </strong>Hypercalcemia-induced bradycardia, though rare, is fully reversible with prompt metabolic correction. Awareness of this atypical presentation can prevent misdiagnosis, unnecessary pacemaker implantation, and delayed recognition of paraneoplastic disease.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2423-2429"},"PeriodicalIF":1.6,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parapharyngeal parotid pleomorphic adenoma: a case report. 咽旁腮腺多形性腺瘤1例。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-20 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004778
Omed Shafiq Hamaamin, Yadgar Abdulhameed Saeed, Ayoub Baqr Razha, Kosar Shirwan Tahir, Mohammed Kakabra Salih, Jeza Muhamad Abdul Aziz, Parshal Bhandari

Introduction and importance: Parapharyngeal space (PPS) tumors are uncommon, accounting for 0.5%-1% of head and neck neoplasms. Diagnosis and treatment of parotid pleomorphic adenomas (PPA) extending to the PPS are difficult because the PPA is situated deep in the tissue.

Case presentation: A 49-year-old woman presented with a sore throat, odynophagia, and foreign body sensation in the throat for 6 weeks. Physical examination revealed a bulge in the oropharynx. Imaging revealed a clearly demarcated lesion in the right PPS of the neck. PPA diagnosis was confirmed using fine-needle aspiration cytology. Surgical removal of the tumor was performed via a transcervical transparotid approach with preservation of the facial nerve. Histopathological examination confirmed the diagnosis of pleomorphic adenoma, and the patient's symptoms were alleviated, with no recurrence at 8 months of follow-up.

Clinical discussion: The clinical onset is typically insidious and is characterized by a gradually enlarging mass in the parotid or upper neck, while oropharyngeal signs, such as dysphagia, snoring, dysphonia, or airway compromise, develop late in the course of the disease when the mass is sufficiently large or manifests as an intraoral bulge in the tonsillar or paratonsillar region.

Conclusion: This case highlights the importance of meticulous diagnosis using radiography and tailored surgical treatment for PPA in PPS. The transcervical transparotid approach enables tumor removal while preserving facial nerve function.

简介及重要性:咽旁间隙(PPS)肿瘤并不常见,约占头颈部肿瘤的0.5%-1%。腮腺多形性腺瘤(PPA)的诊断和治疗是困难的,因为PPA位于组织深处。病例介绍:一名49岁女性,咽喉痛,咽痛,咽喉有异物感6周。体格检查发现口咽部有一个肿块。影像学显示在颈部右PPS有清晰的病灶。细针穿刺细胞学证实PPA诊断。手术切除肿瘤是通过经颈经腮腺入路,并保留面神经。组织病理学检查证实为多形性腺瘤,患者症状有所缓解,随访8个月无复发。临床讨论:临床发病通常是隐匿的,其特征是腮腺或上颈部的肿块逐渐扩大,而口咽部体征,如吞咽困难、打鼾、发音困难或气道受损,在疾病的后期出现,当肿块足够大或表现为扁桃体或副扁桃体区域的口内隆起。结论:本病例强调了对PPS患者进行细致的影像学诊断和针对性的手术治疗的重要性。经颈经腮腺入路可以在保留面神经功能的同时切除肿瘤。
{"title":"Parapharyngeal parotid pleomorphic adenoma: a case report.","authors":"Omed Shafiq Hamaamin, Yadgar Abdulhameed Saeed, Ayoub Baqr Razha, Kosar Shirwan Tahir, Mohammed Kakabra Salih, Jeza Muhamad Abdul Aziz, Parshal Bhandari","doi":"10.1097/MS9.0000000000004778","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004778","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Parapharyngeal space (PPS) tumors are uncommon, accounting for 0.5%-1% of head and neck neoplasms. Diagnosis and treatment of parotid pleomorphic adenomas (PPA) extending to the PPS are difficult because the PPA is situated deep in the tissue.</p><p><strong>Case presentation: </strong>A 49-year-old woman presented with a sore throat, odynophagia, and foreign body sensation in the throat for 6 weeks. Physical examination revealed a bulge in the oropharynx. Imaging revealed a clearly demarcated lesion in the right PPS of the neck. PPA diagnosis was confirmed using fine-needle aspiration cytology. Surgical removal of the tumor was performed via a transcervical transparotid approach with preservation of the facial nerve. Histopathological examination confirmed the diagnosis of pleomorphic adenoma, and the patient's symptoms were alleviated, with no recurrence at 8 months of follow-up.</p><p><strong>Clinical discussion: </strong>The clinical onset is typically insidious and is characterized by a gradually enlarging mass in the parotid or upper neck, while oropharyngeal signs, such as dysphagia, snoring, dysphonia, or airway compromise, develop late in the course of the disease when the mass is sufficiently large or manifests as an intraoral bulge in the tonsillar or paratonsillar region.</p><p><strong>Conclusion: </strong>This case highlights the importance of meticulous diagnosis using radiography and tailored surgical treatment for PPA in PPS. The transcervical transparotid approach enables tumor removal while preserving facial nerve function.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2430-2433"},"PeriodicalIF":1.6,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The rising burden of obesity-linked cancers in Saudi Arabia: a public health review. 沙特阿拉伯与肥胖有关的癌症负担日益加重:一项公共卫生审查。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-20 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004775
Mohsin Yahya Murshid, Esam Mohammad Murshid, Nedal Bukhari, Mohammad Alfayez, Tareq Salah, Yasir Bahadur

Obesity is a growing global health crisis with wide-ranging effects beyond metabolic and cardiovascular disorders. A substantial body of international evidence has linked excess adiposity to increased risk for various cancers. In Saudi Arabia, where obesity rates are among the highest globally, the relationship between obesity and cancer remains insufficiently characterized. This narrative review synthesizes global and regional literature on obesity-associated cancers, with a specific focus on the epidemiologic and research landscape in Saudi Arabia. A targeted search of PubMed, Google Scholar, and official databases from the World Health Organization, International Agency for Research on Cancer, and GLOBOCAN was conducted for English-language articles published between 1990 and 2023. The review highlights several cancers - postmenopausal breast, colorectal, liver, endometrial, kidney, and pancreatic - with convincing or probable associations with obesity. Alarmingly, many of these cancers also rank among the most common and fatal malignancies in Saudi Arabia, as shown in GLOBOCAN 2022 data. However, local research quantifying this link is limited. National cancer registries lack obesity-related variables, and longitudinal cohort studies are scarce. These gaps hinder the ability to implement evidence-based, obesity-targeted cancer prevention strategies. Given the convergence of high obesity prevalence and rising incidence of obesity-related cancers, urgent attention is needed to integrate obesity metrics into national cancer surveillance. Strategic investments in population-based cohort studies and registry reform are essential to inform tailored public health interventions and reduce the burden of obesity-related cancers in the Kingdom.

肥胖是一个日益严重的全球健康危机,其影响不仅限于代谢和心血管疾病。大量国际证据表明,过度肥胖会增加患各种癌症的风险。在全球肥胖率最高的沙特阿拉伯,肥胖和癌症之间的关系仍然没有得到充分的描述。这篇叙述性综述综合了全球和地区关于肥胖相关癌症的文献,特别关注沙特阿拉伯的流行病学和研究概况。对PubMed、谷歌Scholar以及世界卫生组织、国际癌症研究机构和GLOBOCAN的官方数据库进行了有针对性的搜索,以获取1990年至2023年间发表的英语文章。该综述强调了几种癌症——绝经后乳腺癌、结肠直肠癌、肝癌、子宫内膜癌、肾癌和胰腺癌——与肥胖有令人信服的或可能的关联。令人震惊的是,如GLOBOCAN 2022数据所示,这些癌症中的许多也是沙特阿拉伯最常见和最致命的恶性肿瘤之一。然而,国内量化这一联系的研究有限。国家癌症登记处缺乏与肥胖相关的变量,而且纵向队列研究很少。这些差距阻碍了以证据为基础、以肥胖为目标的癌症预防战略的实施。鉴于高肥胖患病率和肥胖相关癌症发病率上升的趋同,迫切需要关注将肥胖指标纳入国家癌症监测。在以人口为基础的队列研究和登记改革方面的战略投资对于为有针对性的公共卫生干预提供信息和减轻沙特王国肥胖相关癌症的负担至关重要。
{"title":"The rising burden of obesity-linked cancers in Saudi Arabia: a public health review.","authors":"Mohsin Yahya Murshid, Esam Mohammad Murshid, Nedal Bukhari, Mohammad Alfayez, Tareq Salah, Yasir Bahadur","doi":"10.1097/MS9.0000000000004775","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004775","url":null,"abstract":"<p><p>Obesity is a growing global health crisis with wide-ranging effects beyond metabolic and cardiovascular disorders. A substantial body of international evidence has linked excess adiposity to increased risk for various cancers. In Saudi Arabia, where obesity rates are among the highest globally, the relationship between obesity and cancer remains insufficiently characterized. This narrative review synthesizes global and regional literature on obesity-associated cancers, with a specific focus on the epidemiologic and research landscape in Saudi Arabia. A targeted search of PubMed, Google Scholar, and official databases from the World Health Organization, International Agency for Research on Cancer, and GLOBOCAN was conducted for English-language articles published between 1990 and 2023. The review highlights several cancers - postmenopausal breast, colorectal, liver, endometrial, kidney, and pancreatic - with convincing or probable associations with obesity. Alarmingly, many of these cancers also rank among the most common and fatal malignancies in Saudi Arabia, as shown in GLOBOCAN 2022 data. However, local research quantifying this link is limited. National cancer registries lack obesity-related variables, and longitudinal cohort studies are scarce. These gaps hinder the ability to implement evidence-based, obesity-targeted cancer prevention strategies. Given the convergence of high obesity prevalence and rising incidence of obesity-related cancers, urgent attention is needed to integrate obesity metrics into national cancer surveillance. Strategic investments in population-based cohort studies and registry reform are essential to inform tailored public health interventions and reduce the burden of obesity-related cancers in the Kingdom.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2335-2347"},"PeriodicalIF":1.6,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
YCT-529: a promising oral non-hormonal male contraceptive and its implications for family planning. YCT-529:一种有前景的口服非激素男性避孕药及其对计划生育的影响。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-18 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004801
Hamza Sajid, Fatima Imran, Noor Un Nisa Irshad, Sakan Binte Imran
{"title":"YCT-529: a promising oral non-hormonal male contraceptive and its implications for family planning.","authors":"Hamza Sajid, Fatima Imran, Noor Un Nisa Irshad, Sakan Binte Imran","doi":"10.1097/MS9.0000000000004801","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004801","url":null,"abstract":"","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2460-2461"},"PeriodicalIF":1.6,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophilic gastroenteritis in a 45-year-old female with epigastric abdominal pain: a rare case report. 45岁女性嗜酸性胃肠炎伴上腹部疼痛:罕见病例报告。
IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-02-18 eCollection Date: 2026-03-01 DOI: 10.1097/MS9.0000000000004793
Ayham Mousa, Laila Daas, Mohamad Nour Hababeh, Betoul Alhofari, Loujain Thalaj, Leen Al Erksoussi, Jana Abo Shukr, Leen Salman, Bilal Sleiay, Mouhammed Sleiay

Introduction and importance: Eosinophilic gastroenteritis (EGE) is a rare condition characterized by eosinophilic infiltration of the gastrointestinal tract, commonly presenting with abdominal pain, diarrhea, and peripheral eosinophilia. Corticosteroids are traditionally considered the mainstay of treatment.

Case presentation: A 45-year-old female presented with epigastric abdominal pain. Laboratory tests revealed marked peripheral eosinophilia, and upper endoscopy with biopsies confirmed mucosal-type EGE. The patient declined corticosteroid therapy and was commenced on montelukast 10 mg daily. She achieved complete symptom resolution within 2 weeks and maintained remission over a 12-month follow-up.

Clinical discussion: Corticosteroids remain the standard treatment for EGE, effectively reducing eosinophil counts and inflammatory mediators. In patients unable or unwilling to receive steroids, leukotriene receptor antagonists, such as montelukast, offer a viable alternative, demonstrating rapid symptom relief and potential for sustained remission.

Conclusion: Physicians should recognize EGE and its therapeutic complexities. Montelukast may serve as an effective corticosteroid-sparing strategy, enabling early symptom resolution and long-term remission.

简介及重要性:嗜酸性胃肠炎(EGE)是一种罕见的以胃肠道嗜酸性粒细胞浸润为特征的疾病,通常表现为腹痛、腹泻和外周嗜酸性粒细胞增多。传统上,皮质类固醇被认为是主要的治疗方法。病例介绍:一名45岁女性,表现为上腹部疼痛。实验室检查显示明显的外周嗜酸性粒细胞增多,上腔镜活检证实为粘膜型EGE。患者减少皮质类固醇治疗,开始使用孟鲁司特10mg每日。患者在2周内症状完全缓解,并在12个月的随访中保持缓解。临床讨论:糖皮质激素仍然是EGE的标准治疗,有效地减少嗜酸性粒细胞计数和炎症介质。对于不能或不愿接受类固醇治疗的患者,白三烯受体拮抗剂,如孟鲁司特,提供了一种可行的替代方案,显示出快速缓解症状和持续缓解的潜力。结论:医师应认识到EGE及其治疗的复杂性。孟鲁司特可能作为有效的皮质类固醇保留策略,使早期症状解决和长期缓解。
{"title":"Eosinophilic gastroenteritis in a 45-year-old female with epigastric abdominal pain: a rare case report.","authors":"Ayham Mousa, Laila Daas, Mohamad Nour Hababeh, Betoul Alhofari, Loujain Thalaj, Leen Al Erksoussi, Jana Abo Shukr, Leen Salman, Bilal Sleiay, Mouhammed Sleiay","doi":"10.1097/MS9.0000000000004793","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004793","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Eosinophilic gastroenteritis (EGE) is a rare condition characterized by eosinophilic infiltration of the gastrointestinal tract, commonly presenting with abdominal pain, diarrhea, and peripheral eosinophilia. Corticosteroids are traditionally considered the mainstay of treatment.</p><p><strong>Case presentation: </strong>A 45-year-old female presented with epigastric abdominal pain. Laboratory tests revealed marked peripheral eosinophilia, and upper endoscopy with biopsies confirmed mucosal-type EGE. The patient declined corticosteroid therapy and was commenced on montelukast 10 mg daily. She achieved complete symptom resolution within 2 weeks and maintained remission over a 12-month follow-up.</p><p><strong>Clinical discussion: </strong>Corticosteroids remain the standard treatment for EGE, effectively reducing eosinophil counts and inflammatory mediators. In patients unable or unwilling to receive steroids, leukotriene receptor antagonists, such as montelukast, offer a viable alternative, demonstrating rapid symptom relief and potential for sustained remission.</p><p><strong>Conclusion: </strong>Physicians should recognize EGE and its therapeutic complexities. Montelukast may serve as an effective corticosteroid-sparing strategy, enabling early symptom resolution and long-term remission.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2434-2437"},"PeriodicalIF":1.6,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Medicine and Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1